PMID-28853087 – EDR Tripeptide Restores Neuronal Spines Alzheimers Model
Khavinson VK, Linkova NS, Kukanova EO, Bolshakova AV, Samoilova EV, Yankelevich IA. Tripeptides Restore the Number of Neuronal Spines under Conditions of In Vitro Modeled Alzheimer's Disease. Bull Exp Biol Med. 2017;163(4):462-465.
Quick Reference
| Property | Value |
|---|---|
| PMID | 28853087 |
| DOI | 10.1007/s10517-017-3828-x |
| Year | 2017 |
| Journal | Bulletin of Experimental Biology and Medicine |
| Study Type | In vitro |
| Evidence Level | V |
| Sample | Mouse hippocampal neuron cultures |
| Peptide(s) Studied | Pinealon |
Key Findings
- EDR (Glu-Asp-Arg / pinealon) at 200 ng/ml increased mushroom dendritic spines by 71% under amyloid synaptotoxicity conditions
- Treatment restored mushroom spine numbers to near-normal levels in Alzheimer's disease model
- Mushroom spines are critical for stable synaptic connections and memory formation
- The protective effect was specific to the mature mushroom spine type (functionally most important)
- Other tripeptides (KE, AED) were also tested with varying effects
- Amyloid beta-induced synaptotoxicity was significantly attenuated by EDR treatment
Study Design
In vitro Alzheimer's disease model using primary hippocampal neuron cultures from mice. Neurons were exposed to amyloid beta oligomers (to induce synaptotoxicity) with or without EDR tripeptide treatment. Dendritic spine morphology quantified by confocal microscopy and classified by type (mushroom, thin, stubby).
Limitations
- In vitro study; in vivo cognitive effects not assessed
- Khavinson group (single research team)
- Alzheimer's disease model is simplified compared to human pathology
- Amyloid-centric model may not capture full AD pathophysiology
- No dose-response data presented
Clinical Relevance
Demonstrates that pinealon/EDR can protect synaptic structures critical for memory under Alzheimer's-like conditions. The 71% increase in mushroom spines is a substantial effect size. Mushroom spines are considered the structural correlate of long-term memory, making their preservation a meaningful therapeutic endpoint. This supports further investigation of pinealon for age-related cognitive decline and neurodegenerative conditions. Note: Independent replication of these findings is needed.
Related
#research #in-vitro #pinealon #evidence-level-V